Men with testosterone deficiency and a history of cardiovascular diseases benefit from long-term testosterone therapy: observational, real-life data from a registry study

References

• MorgentalerAMinerMMCaliberMGuayATKheraMTraishAMTestosterone therapy and cardiovascular risk: advances and controversiesMayo Clin Proc201590222425125636998
   PubMed Web of Science ®Google Scholar
• TraishAMAdverse health effects of testosterone deficiency (TD) in menSteroids20148810611624942084
   PubMed Web of Science ®Google Scholar
• JespersenCGNørgaardMBorreMAndrogen-deprivation therapy in treatment of prostate cancer and risk of myocardial infarction and stroke: a nationwide Danish population-based cohort studyEur Urol201465470470923433805
   PubMed Web of Science ®Google Scholar
• RosanoGMSheibanIMassaroRLow testosterone levels are associated with coronary artery disease in male patients with anginaInt J Impot Res200719217618216943795
   PubMed Web of Science ®Google Scholar
• SrinathRHill GoldenSCarsonKADobsAEndogenous testosterone and its relationship to preclinical and clinical measures of cardiovascular disease in the atherosclerosis risk in communities studyJ Clin Endocrinol Metab201510041602160825584720
   PubMed Web of Science ®Google Scholar
• LaaksonenDENiskanenLPunnonenKTestosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged menDiabetes Care20042751036104115111517
   PubMed Web of Science ®Google Scholar
• AntonioLWuFCO’NeillTWEMAS Study GroupAssociations between sex steroids and the development of metabolic syndrome: a longitudinal study in European menJ Clin Endocrinol Metab201510041396140425636052
   PubMed Web of Science ®Google Scholar
• NarayananKHavmoellerRReinierKSex hormone levels in patients with sudden cardiac arrestHeart Rhythm201411122267227225240696
   PubMed Web of Science ®Google Scholar
• BasariaSCovielloADTravisonTGAdverse events associated with testosterone administrationN Engl J Med2010363210912220592293
   PubMed Web of Science ®Google Scholar
• XuLFreemanGCowlingBJSchoolingCMTestosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trialsBMC Med2013181110823597181
   PubMedGoogle Scholar
• VigenRO’DonnellCIBarónAEAssociation of testosterone therapy with mortality, myocardial infarction, and stroke in men with low testosterone levelsJAMA2013310171829183624193080
   PubMed Web of Science ®Google Scholar
  ErratumJAMA20143119967
   Web of Science ®Google Scholar
• FinkleWDGreenlandSRidgewayGKIncreased risk of nonfatal myocardial infarction following testosterone therapy prescription in menPLoS One201491e8580524489673
   PubMed Web of Science ®Google Scholar
• BaillargeonJUrbanRJKuoYFRisk of myocardial infarction in older men receiving testosterone therapyAnn Pharmacother20144891138114424989174
   PubMed Web of Science ®Google Scholar
• BaillargeonJUrbanRJMorgentalerARisk of venous thromboembolism in men receiving testosterone therapyMayo Clin Proc20159081038104526205547
   PubMed Web of Science ®Google Scholar
• SharmaROniOAGuptaKNormalization of testosterone level is associated with reduced incidence of myocardial infarction and mortality in menEur Heart J201536402706271526248567
   PubMed Web of Science ®Google Scholar
• TanRSCookKRReillyWGMyocardial infarction and stroke risk in young healthy men treated with injectable testosteroneInt J Endocrinol2015201597075026124832
   PubMed Web of Science ®Google Scholar
• EtminanMSkeldonSCGoldenbergSLCarletonBBrophyJMTestosterone therapy and risk of myocardial infarction: a pharmacoepidemiologic studyPharmacotherapy2015351727825582846
   PubMed Web of Science ®Google Scholar
• AndersonJLMayHTLappéDLImpact of testosterone replacement therapy on myocardial infarction, stroke, and death in men with low testosterone concentrations in an integrated healthcare systemAm J Cardiol2016117579479926772440
   PubMed Web of Science ®Google Scholar
• TraishAMHaiderADorosGSaadFLong-term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long-term registry studyInt J Clin Pract201468331432924127736
   PubMed Web of Science ®Google Scholar
• SaadFHaiderADorosGTraishALong-term treatment of hypogonadal men with testosterone produces substantial and sustained weight lossObesity (Silver Spring)201321101975198123512691
   PubMed Web of Science ®Google Scholar
• SaadFYassinADorosGHaiderAEffects of long-term treatment with testosterone on weight and waist size in 411 hypogonadal men with obesity classes I–III: observational data from two registry studiesInt J Obes2016401162170
   PubMed Web of Science ®Google Scholar
• PietriPVlachopoulosCIoakeimidisN5B.06: association of plasma testosterone with central haemodynamics in hypertensive menJ Hypertens201533suppl 1e6726102895
   PubMedGoogle Scholar
• HackettGColeNBhartiaMBLAST Study GroupTestosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST studyJ Sex Med201411384085624308723
   PubMed Web of Science ®Google Scholar
• JonesTHArverSBehreHMTestosterone replacement in hypogonadal men with type 2diabetes and/or metabolic syndrome (the TIMES2 study)Diabetes Care201134482883721386088
   PubMed Web of Science ®Google Scholar
• NedogodaSVBarykinaINSalasyukASSmirnovaVOKhripaevaVJEffects of testosterone replacement therapy on cardio-metabolic, hormonal and anthropometric parameters in obese hypogonadal men with metabolic syndromeObesity20151217
   Google Scholar
• FrancomanoDLenziAAversaAEffects of five-year treatment with testosterone undecanoate on metabolic and hormonal parameters in ageing men with metabolic syndromeInt J Endocrinol2014201452747024688542
   PubMed Web of Science ®Google Scholar
• AversaABruzzichesRFrancomanoDEffects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled studyAging Male20121529610222439807
   PubMed Web of Science ®Google Scholar
• SvartbergJvon MühlenDSchirmerHBarrett-ConnorESundfjordJJordeRAssociation of endogenous testosterone with blood pressure and left ventricular mass in men. Tromsø StudyEur J Endocrinol20041501657114713281
   PubMed Web of Science ®Google Scholar
• DockeryFBulpittCJAgarwalSDonaldsonMRajkumarCTestosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemiaClin Sci2003104219520112546642
   PubMed Web of Science ®Google Scholar
• VlachopoulosCIoakeimidisNMinerMTestosterone deficiency: a determinant of aortic stiffness in menAtherosclerosis2014233127828324529157
   PubMed Web of Science ®Google Scholar
• OhlssonCBarrett-ConnorEBhasinSHigh serum testosterone is associated with reduced risk of cardiovascular events in elderly men. The MrOS (Osteoporotic fractures in men) study in SwedenJ Am Coll Cardiol201158161674168221982312
   PubMed Web of Science ®Google Scholar
• ShoresMMSmithNLForsbergCWAnawaltBDMatsumotoAMTestosterone treatment and mortality in men with low testosterone levelsJ Clin Endocrinol Metab20129762050205822496507
   PubMed Web of Science ®Google Scholar
• MuraleedharanVMarshHKapoorDChannerKSJonesTHTestosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetesEur J Endocrinol2013169672573323999642
   PubMed Web of Science ®Google Scholar
• CoronaGMaseroliERastrelliGCardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysisExpert Opin Drug Saf201413101327135125139126
   PubMed Web of Science ®Google Scholar
• HackettGColeNBhartiaMKennedyDRajuJWilkinsonPTestosterone replacement therapy with long-acting testosterone undecanoate improves sexual function and quality of-life parameters vs. placebo in a population of men with type 2 diabetesJ Sex Med20131061612162723551886
   PubMed Web of Science ®Google Scholar
• TongSFNgCJLeeBCEffect of long-acting testosterone undecanoate treatment on quality of life in men with testosterone deficiency syndrome: a double blind randomized controlled trialAsian J Androl201214460461122635164
   PubMed Web of Science ®Google Scholar
• Srinivas-ShankarURobertsSAConnollyMJEffects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled studyJ Clin Endocrinol Metab201095263965020061435
   PubMed Web of Science ®Google Scholar
• ZitzmannMMatternAHanischJGoorenLJonesHMaggiMIPASS: a Study on the tolerability and effectiveness of injectable testosterone undecanoate for the treatment of male hypogonadism in a worldwide sample of 1438 menJ Sex Med201310257958822812645
   PubMed Web of Science ®Google Scholar
• MorgunovLDenisolaIRohzkovaTStakhovskayaLVSkvortsovaVIAndrogen deficit and its treatment in stroke male patients with type II diabetesZh Nevrol Psikhiatr Im S S Korsakova201182212422224240
   PubMedGoogle Scholar
• CohenATGotoSSchreiberKTorp-PedersenCWhy do we need observational studies of everyday patients in the real-life setting?Eur Heart J Suppl201517suppl DD2D8
   Web of Science ®Google Scholar